Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Rapid Diagnostic Testing 2022 - SARS-CoV-2 & Beyond

Peter Ertl's Biography

Peter Ertl, Professor of Lab-on-a-Chip Systems, Vienna University of Technology

Prof. Ertl holds an engineering degree in Biotechnology (University of Life Sciences, BOKU, Austria), a PhD in Chemistry (University of Waterloo, UW, Canada) and received his postdoctoral training as a biophysicist at University of California at Berkeley (UCB, US). Following a position as Director of Product Development at a UW spin-off venture (Canada), Dr. Ertl joint the Biosensor Technology unit at the Austrian Institute of Technology (AIT). During his tenure at the AIT, Dr. Ertl was also granted a Fulbright Visiting Scholarship at UC Berkeley (2012) and conducted visiting scientist positions at Nanyang Technological University, Singapore (2013), the Medical Center of the University of California at San Francisco (2014). In 2016 he was appointed Professor of Lab-on-a-Chip Systems for Bioscience Technologies at the Vienna University of Technology (TUW), where his research focuses on the development of advanced in vitro diagnostic microsystems and organ-on-a-chip systems. Additionally, Dr Ertl held a visiting research appointment at Imperial College London (UK) in 2019 , is speaker of the Austrian Microfluidics Initiative (AMI) and editor of the open access journal Organs-on-a-Chip (Elsevier).

Peter Ertl Image

Managing COVID Pandemic Using Rapid Testing Systems: An Austrian Perspective

Monday, 21 March 2022 at 17:30

Add to Calendar ▼2022-03-21 17:30:002022-03-21 18:30:00Europe/LondonManaging COVID Pandemic Using Rapid Testing Systems: An Austrian PerspectiveRapid Diagnostic Testing 2022 - SARS-CoV-2 and Beyond in

The incidence of viral distribution and infection has soared over the past decades due to population growth and increased travel, resulting in a global pandemic caused by SARS-CoV-2 viral outbreak. As a consequence, rapid detection and identification of viral infections is a pressing human health issue. Faster, more accurate diagnosis will benefit health care systems, in particular by significantly reducing time-to-result and providing better more reliable epidemiological data that can be used for infectious disease control. In course of the present presentation current Covid-19 test kits are reviewed and evaluated for point-of-care and on-site applications. Additionally, our efforts to develop a self-powered sensing solution combining liquid handling, microbatteries, optical read out unit microsensor arrays on a fully integrated and stand-alone lab-on-a-chip system will be discussed.

Add to Calendar ▼2022-03-21 00:00:002022-03-22 00:00:00Europe/LondonRapid Diagnostic Testing 2022 - SARS-CoV-2 and BeyondRapid Diagnostic Testing 2022 - SARS-CoV-2 and Beyond in